首頁 › 鐮狀細胞病 › 北卡羅來納州 › Greenville
Greenville, NC 的 鐮狀細胞病 臨床試驗
9 項針對 鐮狀細胞病 的研究正在 Greenville（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
招募中1 期
- Brody School of Medicine at East Carolina University, Greenville
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- East Carolina University, Greenville
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
招募中3 期
- East Carolina Univ-Greenville, Greenville
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
招募中1/2 期歡迎健康志工
- East Carolina University, Greenville
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
招募中2/3 期
- ECU Physicians, Brody Outpatient Clinic, Greenville
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
招募中1/2 期歡迎健康志工
- Local Institution - 0033, Greenville
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中觀察性研究
- East Carolina University Hemophilia Treatment Center, Greenville
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
招募中2 期
- East Carolina University, Greenville
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
招募中
- East Carolina University Health Medical Center, Greenville
其他城市的 鐮狀細胞病 試驗
- Atlanta, GA22 項研究
- Washington, DC20 項研究
- Chicago, IL18 項研究
- Memphis, TN18 項研究
- Philadelphia, PA15 項研究
- Birmingham, AL14 項研究
- New York City, NY13 項研究
- St. Louis, MO12 項研究
- Boston, MA10 項研究
- Durham, NC10 項研究
- Houston, TX10 項研究
- Cincinnati, OH10 項研究
Greenville 的其他研究
- 急性髓系白血病10 項研究
- 特發性血小板減少性紫斑病6 項研究
- 心臟衰竭6 項研究
- 慢性淋巴性白血病5 項研究
- 伯基特淋巴瘤5 項研究
- 肥胖症5 項研究
- 第二型糖尿病5 項研究
- 血液疾病5 項研究
- 癌症（所有類型）4 項研究
- 自體免疫疾病4 項研究
- 骨髓增生性腫瘤4 項研究
- 骨髓增生異常症候群4 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。